Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy
Abstract
Authors
A. Miquel Cases L.M.G. Steuten V.P. Retèl W.H. van Harten